Assessing the impact of Span 60 and cholesterol on mupirocin niosomes developed for topical delivery
DOI:
https://doi.org/10.60988/p.v37i2S.195Keywords:
mupirocin; niosome; topical delivery; vesicle size; entrapment efficiencyAbstract
Mupirocin (MUP), a broad-spectrum antibacterial agent, is commonly used in order to treat superficial skin infections. However, its therapeutic efficacy is limited by poor skin permeability and the impracticality of prolonged topical administration. This study reports the development of a niosomal delivery system engineered so as to enhance topical MUP delivery by optimizing vesicle size and drug entrapment efficiency. Niosomes were prepared using the thin-film hydration method, and a 22 full factorial design was employed in order to optimize formulations based on Span 60 and cholesterol concentrations. Vesicle size and entrapment efficiency served as dependent variables. Both models were significant, thereby indicating that formulation variables and their interactions substantially influenced vesicle characteristics. The findings demonstrate that a full factorial design is an effective approach to elucidate and optimize the impact of formulation variables on MUP-loaded niosomes.
References
1. Williamson D.A., Carter G.P., Howden B.P. Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns. Clin. Microbiol. Rev. 30(3), 827–860, 2017. DOI: 10.1128/CMR.00112-16
2. Alhasso B., Ghori M.U., Conway B.R. Development of nanoemulsions for topical application of mupirocin. Pharmaceutics 15(2), 378, 2023. DOI: 10.3390/pharmaceutics15020378
3. Mawazi S.M., Ge Y., Widodo R.T. Niosome preparation techniques and structure – an illustrated review. Pharmaceutics 17(1), 67, 2025. DOI: 10.3390/pharmaceutics17010067
4. Liga S., Paul C., Moacă E.A., Péter F. Niosomes: composition, formulation techniques, and recent progress as delivery systems in cancer therapy. Pharmaceutics 16(2), 223, 2024. DOI: 10.3390/pharmaceutics16020223
5. Al-Edhari G.H., Al Gawhari F.J. Study the effect of formulation variables on preparation of nisoldipine loaded nano bilosomes. Iraqi J. Pharm. Sci. 32(s), 271–282, 2023. DOI: 10.31351/vol32issSuppl.pp271-282
6. Alkawak R.S.Y., Rajab N.A. Lornoxicam-loaded cubosomes: preparation and in vitro characterization. Iraqi J. Pharm. Sci. 31(1), 144–153, 2022. DOI: 10.31351/vol31iss1pp144-153
7. El-Nabarawi M.A., Shamma R.N., Farouk F., Nasralla S.M. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. J. Liposome Res. 30(1), 1–11, 2020. DOI: 10.1080/08982104.2019.1577256
8. Essa E.A. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J. Pharm. 4(4), 227–233, 2010. DOI: 10.22377/ajp.v4i4.289
9. Abdelbary G.A., Aburahma M.H. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. J. Liposome Res. 25(2), 107–121, 2015. DOI: 10.3109/08982104.2014.941861
10. Albassam N.Y., Kassab H.J. Diacerein loaded novasome for transdermal delivery: preparation, in vitro characterization and factors affecting formulation. Iraqi J. Pharm. Sci. 32(s), 214–224, 2023. DOI: 10.31351/vol32issSuppl.pp214-224
